Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Talis Biomedical Corp (TLIS)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsJun-30-23Mar-31-23Dec-31-22Sep-30-22Jun-30-22Mar-31-22Dec-31-21Sep-30-21
   10-Q10-Q10-K10-Q10-Q10-Q10-K10-Q
Revenues  2.92.84.85.44.84.48.2 
            Revenue growth  -41.0%-35.1%-41.3%     
Cost of goods sold  3.64.98.46.14.83.50.0 
Gross profit  -0.7-2.0-3.6-0.60.00.98.2 
            Gross margin  -26.1%-72.0%-74.4%-11.9%0.2%19.6%100.0% 
Selling, general and administrative   [+]37.547.059.556.168.4106.4141.3 
Other operating expenses    52.1   58.8 
EBITDA   [+]-82.5-92.5-106.3-109.3-124.7-162.5-190.2 
            EBITDA margin  -2891.2%-3254.6%-2209.2%-2020.0%-2578.4%-3710.9%-2322.0% 
Depreciation and amortization  7.88.68.86.22.51.71.6 
EBIT   [+]-90.3-101.2-115.1-115.5-127.2-164.3-191.8 
            EBIT margin  -3165.7%-3558.5%-2392.7%-2134.6%-2630.3%-3750.3%-2341.2% 
Other income (expense), net   [+]4.53.42.10.80.0-0.3-0.2 
Pre-tax income  -85.8-97.8-113.0-114.7-127.1-164.6-192.0 
Income taxes  0.00.00.00.00.00.00.0 
            Tax rate  0.0%0.0%0.0%0.0%0.0%0.0%0.0% 
Net income  -85.8-97.8-113.0-114.7-127.1-164.6-192.0 
            Net margin  -3008.9%-3439.7%-2348.5%-2119.7%-2629.5%-3757.9%-2343.9% 
   
Basic EPS   [+]($4.19)($4.78)($5.54)($5.92)($6.63)($6.55)($8.81) 
Diluted EPS   [+]($4.19)($4.78)($5.54)($5.92)($6.63)($6.55)($8.81) 
   
Shares outstanding (basic)   [+]20.520.520.419.419.225.121.8 
Shares outstanding (diluted)   [+]20.520.520.419.419.225.121.8 
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy